Oxaceprol: Difference between revisions

	WikiDoc Resources for Oxaceprol
Articles
Most recent articles on Oxaceprol Most cited articles on Oxaceprol Review articles on Oxaceprol Articles on Oxaceprol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Oxaceprol Images of Oxaceprol Photos of Oxaceprol Podcasts & MP3s on Oxaceprol Videos on Oxaceprol
Evidence Based Medicine
Cochrane Collaboration on Oxaceprol Bandolier on Oxaceprol TRIP on Oxaceprol
Clinical Trials
Ongoing Trials on Oxaceprol at Clinical Trials.gov Trial results on Oxaceprol Clinical Trials on Oxaceprol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Oxaceprol NICE Guidance on Oxaceprol NHS PRODIGY Guidance FDA on Oxaceprol CDC on Oxaceprol
Books
Books on Oxaceprol
News
Oxaceprol in the news Be alerted to news on Oxaceprol News trends on Oxaceprol
Commentary
Blogs on Oxaceprol
Definitions
Definitions of Oxaceprol
Patient Resources / Community
Patient resources on Oxaceprol Discussion groups on Oxaceprol Patient Handouts on Oxaceprol Directions to Hospitals Treating Oxaceprol Risk calculators and risk factors for Oxaceprol
Healthcare Provider Resources
Symptoms of Oxaceprol Causes & Risk Factors for Oxaceprol Diagnostic studies for Oxaceprol Treatment of Oxaceprol
Continuing Medical Education (CME)
CME Programs on Oxaceprol
International
Oxaceprol en Espanol Oxaceprol en Francais
Business
Oxaceprol in the Marketplace Patents on Oxaceprol
Experimental / Informatics
List of terms related to Oxaceprol

Oxaceprol
Clinical data
Synonyms	(2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid
AHFS/Drugs.com	International Drug Names
ATC code	D11AX09 (WHO) M01AX24 (WHO);
Identifiers
	IUPAC name (4R)-1-acetyl-4-hydroxy-L-proline;
CAS Number	33996-33-7 ;
PubChem CID	65784;
ChemSpider	59203;
UNII	Q0XV76B96L;
KEGG	D07215 ;
ChEMBL	ChEMBL1407356;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C7H11NO4
Molar mass	172.159 g/mol
3D model (JSmol)	Interactive image;
	SMILES CC(=O)N1C[C@@H](C[C@H]1C(=O)O)O;
	InChI InChI=1S/C7H11NO4/c1-4(9)8-3-5(10)2-6(8)7(11)12/h5-6,10H,2-3H2,1H3,(H,11,12)/t5-,6+/m1/s1; Key:BAPRUDZDYCKSOQ-RITPCOANSA-N;
(verify)

← Older edit

VisualWikitext

Latest revision as of 16:51, 20 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Oxaceprol is an anti-inflammatory drug used in the treatment of osteoarthritis.^[1] It is derived from L-proline, a DNA-encoded amino acid. The active effect of Oxaceprol is to inhibit the adhesion and migration of white blood cells.

References

↑ Herrmann G; Steeger D; Klasser M; et al. (2000). "Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac". Clin. Rheumatol. 19 (2): 99–104. doi:10.1007/s100670050025. PMID 10791619. Unknown parameter |author-separator= ignored (help)

[pmid10791619-1] Herrmann G; Steeger D; Klasser M; et al. (2000). "Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac". Clin. Rheumatol. 19 (2): 99–104. doi:10.1007/s100670050025. PMID 10791619. Unknown parameter |author-separator= ignored (help)

[1]

@@ Line 2: / Line 2: @@
 | verifiedrevid = 447917039
 | IUPAC_name = (4''R'')-1-acetyl-4-hydroxy-<small>L</small>-proline
-| image = Oxaceprol.svg
+| image = Oxaceprol.png
 | width = 200px
@@ Line 52: / Line 52: @@
 }}
 __NOTOC__
 {{SI}}
 {{CMG}}
 ==Overview==
-'''Oxaceprol''' is an anti-inflammatory drug used in the treatment of [[osteoarthritis]].<ref name="pmid10791619">{{cite journal |author=Herrmann G |title=Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac |journal=Clin. Rheumatol. |volume=19 |issue=2 |pages=99–104 |year=2000 |pmid=10791619 |doi=10.1007/s100670050025 |author-separator=, |author2=Steeger D |author3=Klasser M |display-authors=3 |last4=Wirbitzky |first4=J. |last5=f&#x000Fc;Rst |first5=M. |last6=Venbrocks |first6=R. |last7=Rohde |first7=H. |last8=Jungmichel |first8=D. |last9=Hildebrandt |first9=H. D.}}</ref> It is derived from [[L-proline]], a DNA-encoded [[amino acid]]. The active effect of Oxaceprol is to inhibit the adhesion and migration of [[white blood cell]]s.<ref name="Clayton2007"/>
+'''Oxaceprol''' is an anti-inflammatory drug used in the treatment of [[osteoarthritis]].<ref name="pmid10791619">{{cite journal |author=Herrmann G |title=Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac |journal=Clin. Rheumatol. |volume=19 |issue=2 |pages=99–104 |year=2000 |pmid=10791619 |doi=10.1007/s100670050025 |author-separator=, |author2=Steeger D |author3=Klasser M |display-authors=3 |last4=Wirbitzky |first4=J. |last5=f&#x000Fc;Rst |first5=M. |last6=Venbrocks |first6=R. |last7=Rohde |first7=H. |last8=Jungmichel |first8=D. |last9=Hildebrandt |first9=H. D.}}</ref> It is derived from [[L-proline]], a DNA-encoded [[amino acid]]. The active effect of Oxaceprol is to inhibit the adhesion and migration of [[white blood cell]]s.
 ==References==
-{{reflist|refs=
-<ref name="Clayton2007">{{Citation
- | first1    = James J.
- | last1     = Clayton
- | title     = Nutraceuticals in the Management of Osteoarthritis
- | journal   = Orthopedics
- |date=August 2007
- | volume    = 30
- | issue     = 8
- | url       = http://www.healio.com/orthopedics/journals/ORTHO/%7BD4DA9AAE-37CE-4E4A-9C5E-B518F4CFC952%7D/Nutraceuticals-in-the-Management-of-Osteoarthritis
- | accessdate= 2013-06-08
- | postscript= .
-}}</ref>
-}}
-==References==
 {{reflist|2}}
 {{Other dermatological preparations}}
@@ Line 84: / Line 64: @@
 [[Category:Pyrrolidines]]
-[[Category:Acetamides]]
 [[Category:Alcohols]]
-[[Category:Amino acid derivatives]]
 [[Category:Drug]]

v t e Other dermatological preparations (D11)
Medicated shampoos	Cetrimide - Cadmium compounds - Selenium compounds - Povidone-iodine - Sulfur compounds - Xenysalate
Other dermatologicals	seborrhoeic dermatitis/dandruff (Lithium succinate, Pyrithione zinc) - skin whitening/depigmenting (Hydroquinone, Mequinol, Monobenzone) - anti-inflammatory/Immunomodulators (Oxaceprol, Gamolenic acid), Pimecrolimus, Tacrolimus) - baldness treatments (Finasteride, Minoxidil) - hair growth inhibiting agent (Eflornithine) - other (Calcium gluconate, Magnesium sulfate, Tiratricol)

v t e Nonsteroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)
Pyrazolones / Pyrazolidines	Aminophenazone Ampyrone Azapropazone Clofezone Difenamizole Famprofazone Feprazone Kebuzone Metamizole Mofebutazone Morazone Nifenazone Oxyphenbutazone Phenazone Phenylbutazone Propyphenazone Sulfinpyrazone Suxibuzone^‡
Salicylates	Aspirin (acetylsalicylic acid)^# Aloxiprin Benorylate Carbasalate calcium Diflunisal Dipyrocetyl Ethenzamide Guacetisal Magnesium salicylate Methyl salicylate Salsalate Salicin Salicylamide Salicylic acid (salicylate) Sodium salicylate
Acetic acid derivatives and related substances	Aceclofenac Acemetacin Alclofenac Amfenac Bendazac Bromfenac Bumadizone Bufexamac Diclofenac Difenpiramide Etodolac Felbinac Fenclozic acid Fentiazac Indometacin Indometacin farnesil Isoxepac Ketorolac Lonazolac Oxametacin Prodolic acid Proglumetacin Sulindac Tiopinac Tolmetin Zomepirac^†
Oxicams	Ampiroxicam Droxicam Isoxicam Lornoxicam Meloxicam Piroxicam Tenoxicam
Propionic acid derivatives (profens)	Alminoprofen Benoxaprofen^† Carprofen^‡ Dexibuprofen Dexketoprofen Fenbufen Fenoprofen Flunoxaprofen Flurbiprofen Ibuprofen^# Ibuproxam Indoprofen^† Ketoprofen Loxoprofen Miroprofen Naproxen Oxaprozin Pirprofen Suprofen Tarenflurbil Tepoxalin^‡ Tiaprofenic acid Vedaprofen^‡ Zaltoprofen COX-inhibiting nitric oxide donator: Naproxcinod
N-Arylanthranilic acids (fenamates)	Azapropazone Clonixin Etofenamate Flufenamic acid Flunixin Meclofenamic acid Mefenamic acid Morniflumate Niflumic acid Tolfenamic acid Flutiazin
Coxibs	Apricoxib Celecoxib Cimicoxib^‡ Deracoxib^‡ Etoricoxib Firocoxib^‡ Lumiracoxib^† Mavacoxib^‡ Parecoxib Robenacoxib^‡ Rofecoxib^† Valdecoxib^†
Other	Aminopropionitrile Benzydamine Chondroitin sulfate Diacerein Fluproquazone Glucosamine Glycosaminoglycan Hyperforin Nabumetone Nimesulide Oxaceprol Proquazone Superoxide dismutase/Orgotein Tenidap
Items listed in bold indicate initially developed compounds of specific groups. ^#WHO-EM ^†Withdrawn drugs. ^‡Veterinary use medications.

Oxaceprol: Difference between revisions

Latest revision as of 16:51, 20 August 2015

Overview

References

Navigation menu

Search